Live from Women in Ophthalmology: Discussing residency programs
Manage episode 440558264 series 3560285
On this episode, Laura Enyedi, MD, is live from the Women in Ophthalmology meeting with Pratap Challa, MD, Fasika Woreta, MD, Jennifer Lindsey, MD, and Annie Wishna, MD, discussing residency programs.
- Intro 0:01
- Meet the panel 0:11
- Pratap Challa, MD 0:23
- Fasika Woreta, MD, MPH 1:05
- Jennifer Lindsey, MD, MBA 1:43
- Annie E. Wishna, MD 2:18
- In this episode 2:28
- What are your thoughts on parental leave policies and what are your experiences with it? 2:33
- How do you approach the residency applications when it comes to holistic reviews? 8:15
- Has providing a virtual aspect to the application process increased your numbers? 11:43
- Do you have any advice for applicants? How can they make their application stand out? 12:39
- How are the integrated internships working out? What have been the challenges? 16:50
- What is your favorite book or a book you’ve read recently? 20:50
- Thanks 25:02
Pratap Challa, MD, is a glaucoma specialist, professor of ophthalmology and director of residency education at Duke University.
Laura Enyedi, MD, is a professor of ophthalmology and pediatrics at Duke Eye Center and medical director of South Durham Ophthalmology in North Carolina.
Jennifer Lindsey, MD, MBA, is a board-certified ophthalmologist and the director of resident education at Vanderbilt University.
Annie E. Wishna, MD, is a clinical associate professor of ophthalmology and the director of the residency program at the University of Kansas.
Fasika A. Woreta, MD, MPH, is a cornea and cataract specialist and the Eugene de Juan, MD professor of ophthalmic education at Wilmer Eye Institute’s Baltimore and Columbia locations. She is the director of the eye trauma center, the director of the ophthalmology residency program and vice chair of education at the Wilmer Eye Institute.
We’d love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN.
Disclosures: The guests report no relevant financial disclosures.
30 episodi